Health and Healthcare
Pfizer (PFE) Does Some Good, Viagra Rocks On
Published:
Last Updated:
Once all of the one-time charges were washed out of the numbers, Pfizer recorded adjusted income of $4.2 billion, an increase of 5% compared with $4.0 billion in the year-ago quarter, and EPS of $.62, an increase of 7% compared with $.58 in the year-ago quarter. The firm hit these numbers despite a drop in sales of its Zyrtec and Camptosar products.
Viagra and Lipitor continued to do well, a bit of a commentary on life in the US in 2008.
Perhaps most important, Pfizer upped its forecasts. The pharma firm raised the lower end of its guidance range for full-year 2008 revenues to $48.0 to $49.0 billion from $47.0 to $49.0 billion.
All in all, a pretty outstanding set of numbers
Douglas A. McIntyre
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
